Annual CFF
$42.74 M
-$137.37 M-76.27%
31 December 2023
Summary:
Immunocore Holdings annual cash flow from financing activities is currently $42.74 million, with the most recent change of -$137.37 million (-76.27%) on 31 December 2023. During the last 3 years, it has fallen by -$106.07 million (-71.28%). IMCR annual CFF is now -89.22% below its all-time high of $396.47 million, reached on 31 December 2021.IMCR Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFF
$198.00 K
+$1.02 M+124.21%
30 September 2024
Summary:
Immunocore Holdings quarterly cash flow from financing activities is currently $198.00 thousand, with the most recent change of +$1.02 million (+124.21%) on 30 September 2024. Over the past year, it has dropped by -$10.18 million (-98.09%). IMCR quarterly CFF is now -99.95% below its all-time high of $396.01 million, reached on 31 March 2024.IMCR Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFF
$401.65 M
-$10.18 M-2.47%
30 September 2024
Summary:
Immunocore Holdings TTM cash flow from financing activities is currently $401.65 million, with the most recent change of -$10.18 million (-2.47%) on 30 September 2024. Over the past year, it has increased by +$357.25 million (+804.73%). IMCR TTM CFF is now -5.32% below its all-time high of $424.22 million, reached on 31 March 2024.IMCR TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
IMCR Cash From Financing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -76.3% | -98.1% | +804.7% |
| 3 y3 years | -71.3% | +102.0% | -0.8% |
| 5 y5 years | +10000.0% | - | - |
IMCR Cash From Financing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -89.2% | at low | -100.0% | +102.0% | -5.3% | >+9999.0% |
| 5 y | 5 years | -89.2% | >+9999.0% | -100.0% | +102.0% | -5.3% | >+9999.0% |
| alltime | all time | -89.2% | >+9999.0% | -100.0% | +102.0% | -5.3% | >+9999.0% |
Immunocore Holdings Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $198.00 K(-124.2%) | $401.65 M(-2.5%) |
| June 2024 | - | -$818.00 K(-100.2%) | $411.82 M(-2.9%) |
| Mar 2024 | - | $396.01 M(+6232.1%) | $424.22 M(+1135.1%) |
| Dec 2023 | $42.74 M(-76.3%) | $6.25 M(-39.7%) | $34.35 M(-22.6%) |
| Sept 2023 | - | $10.38 M(-10.4%) | $44.39 M(-73.2%) |
| June 2023 | - | $11.58 M(+88.6%) | $165.43 M(+7.9%) |
| Mar 2023 | - | $6.14 M(-62.3%) | $153.33 M(+5.4%) |
| Dec 2022 | $180.11 M | $16.30 M(-87.6%) | $145.44 M(+4.0%) |
| Sept 2022 | - | $131.41 M(<-9900.0%) | $139.80 M(-8699.5%) |
| June 2022 | - | -$518.40 K(-70.4%) | -$1.63 M(+20.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$1.75 M(-116.4%) | -$1.35 M(-100.5%) |
| Dec 2021 | $396.47 M(+166.4%) | $10.66 M(-206.4%) | $288.19 M(-28.8%) |
| Sept 2021 | - | -$10.02 M(+4014.7%) | $404.69 M(-2.4%) |
| June 2021 | - | -$243.50 K(-100.1%) | $414.71 M(+0.3%) |
| Mar 2021 | - | $287.79 M(+126.3%) | $413.45 M(+161.7%) |
| Dec 2020 | $148.81 M(+111.4%) | $127.16 M(>+9900.0%) | $158.01 M(+412.3%) |
| Sept 2020 | - | $5900.00(-100.4%) | $30.84 M(+0.0%) |
| June 2020 | - | -$1.51 M(-104.7%) | $30.84 M(-4.7%) |
| Mar 2020 | - | $32.35 M | $32.35 M |
| Dec 2019 | $70.39 M(>+9900.0%) | - | - |
| Dec 2018 | $134.80 K | - | - |
FAQ
- What is Immunocore Holdings annual cash flow from financing activities?
- What is the all time high annual CFF for Immunocore Holdings?
- What is Immunocore Holdings annual CFF year-on-year change?
- What is Immunocore Holdings quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Immunocore Holdings?
- What is Immunocore Holdings quarterly CFF year-on-year change?
- What is Immunocore Holdings TTM cash flow from financing activities?
- What is the all time high TTM CFF for Immunocore Holdings?
- What is Immunocore Holdings TTM CFF year-on-year change?
What is Immunocore Holdings annual cash flow from financing activities?
The current annual CFF of IMCR is $42.74 M
What is the all time high annual CFF for Immunocore Holdings?
Immunocore Holdings all-time high annual cash flow from financing activities is $396.47 M
What is Immunocore Holdings annual CFF year-on-year change?
Over the past year, IMCR annual cash flow from financing activities has changed by -$137.37 M (-76.27%)
What is Immunocore Holdings quarterly cash flow from financing activities?
The current quarterly CFF of IMCR is $198.00 K
What is the all time high quarterly CFF for Immunocore Holdings?
Immunocore Holdings all-time high quarterly cash flow from financing activities is $396.01 M
What is Immunocore Holdings quarterly CFF year-on-year change?
Over the past year, IMCR quarterly cash flow from financing activities has changed by -$10.18 M (-98.09%)
What is Immunocore Holdings TTM cash flow from financing activities?
The current TTM CFF of IMCR is $401.65 M
What is the all time high TTM CFF for Immunocore Holdings?
Immunocore Holdings all-time high TTM cash flow from financing activities is $424.22 M
What is Immunocore Holdings TTM CFF year-on-year change?
Over the past year, IMCR TTM cash flow from financing activities has changed by +$357.25 M (+804.73%)